Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06256588
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-02-05
Brief Title:
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline